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Abstract
This study assessed the screening rates for gastric
cancer by two different screening methods, upper
gastrointestinal (UGI) series and endoscopy; inten-
tions to undergo future gastric cancer screening; and
the preferred method of screening. The study popu-
lation was derived from the 2006 Korean National
Cancer Screening Survey. The Korean National Cancer
Screening Survey is an annual cross-sectional survey
that uses nationally representative random sampling
to investigate cancer screening rates. A total of 1,625
Koreans over 40 years of age participated in this study.
Logistic regression was used to identify the factors
associated with undergoing gastric cancer screening,
having an intention to be screened, and preferring one
of the two screening tests. Among the 1,625 subjects,
15.1% had received a UGI, 33.2% had received an
endoscopy, and 43.1% had undergone either or both of
the tests in the previous 2 years. About 52% of people
reported the intention to be screened within the next
2 years. The odds ratio for intending to be screened
was 11.8 and 6.2 higher among those who had
undergone a prior UGI test and an endoscopy test
within the previous 2 years, respectively, than for
those who had never been screened. Among the 1,625
individuals, 67% chose endoscopy and 33% UGI for
their preferred future screening method. Collectively,
our results highlight the preference for endoscopy
testing as a gastric cancer screening method. Pro-
viders’ assessments of individuals’ screening prefer-
ences in combination with intervention strategies to
promote performance of the preferred test may
increase patient compliance with gastric cancer screen-
ing recommendations. (Cancer Epidemiol Biomarkers
Prev 2009;18(5):1390–8)
Introduction
Until recently, gastric cancer was the second most
common type of cancer worldwide. With an estimated
934,000 new cases in 2002 (8.6% of new cancer cases),
gastric cancer fell to fourth place behind cancers of the
lung, breast, and colon and rectum (1). However, gastric
cancer remains the second most common cause of death
from cancer (700,000 deaths annually; ref. 1). Korea and
some parts of eastern Asia have the highest incidences of
gastric cancer in the world (1). Although the incidence
has declined in recent decades, gastric cancer remains the
most frequent cancer diagnosis in Korea (2). Therefore,
the prevention of gastric cancer is a major cancer control
strategy (3-6). Countries such as Japan and Korea, where
gastric cancer is highly prevalent, provide gastric cancer
screening to average-risk population to reduce the
disease burden.
Although the debate over the value and risk of
screening asymptomatic individuals is ongoing, interest
has shifted to determining the preferred screening
strategy and discerning the most effective ways of
implementing screening for the general population (7).
Since 1960, Japan has implemented photofluorography
[via indirect upper gastrointestinal (UGI) series] screen-
ing programs to detect gastric cancer in its early stages
and prevent gastric cancer deaths (8). The cohort studies
conducted in Japan showed a significant gastric cancer
mortality reduction with photofluorography screening
(4, 5). In recent years, endoscopy has replaced photoflu-
orography as the initial mass screening method in several
cities in Japan (9). This technique is increasingly useful
for gastric cancer screening because of its high detection
rate. In a study conducted in Niigata, Japan, the detection
of gastric cancer by endoscopy was about 2.7 to 4.6 times
higher than by a direct or indirect X-ray examination (9).
Despite this promising result, direct evidence about the
effectiveness, complications, and acceptability of endos-
copy among individuals at average risk of gastric cancer
is still not sufficient to justify its use for routine screening
(7). Further, studies conducted outside of Japan have
produced conflicting data about the efficacy of gastric
cancer screening. A case-control study conducted in
Venezuela did not show a reduction in mortality among
persons screened with radiography (10). Singapore has
no nationwide population screening program (7); be-
cause its citizens are at intermediate risk for developing
gastric cancer, screening is more effectively targeted
at high-risk groups rather than at a population level. A
cost-benefit analysis of screening for gastric cancer
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conducted in Singapore showed that screening by
endoscopy was cost effective in moderate to high-risk
populations (11). In China, gastric cancer is the second
most common form of cancer, but no nationwide
screening program is available. Therefore, early detection
of gastric cancer relies on opportunistic screening only.
Endoscopy tests are widely available in major cities, but
barium meal studies (UGI series) and serum pepsinogen
testing are not commonly practiced in China because of
their limited availability (7).
In Korea, screening for gastric cancer started in 1999 as
a part of the National Cancer Screening Program (NCSP)
for low-income groups. Currently, the NCSP provides
Medical Aid recipients and National Health Insurance
beneficiaries within the lower 50% income bracket
with free-of-charge screening services for five common
cancers: gastric, liver, colorectal, breast, and cervix (12).
The NCSP recommends biennial gastric cancer screening
for men and women ages 40 years and older, with either
an UGI series or endoscopy. Under the NCSP, eligible
men and women receive an invitation letter for gastric
cancer screening every 2 years. Those who are invited to
have gastric cancer screening can receive either an UGI
or endoscopy test at a clinic, hospital, or general hospital
that has been designated as a gastric cancer screening
unit by the National Health Insurance Corp. To be
designated as a gastric cancer screening unit, a clinic or
hospital must have both X-ray and endoscopy equipment
and at least one full-time medical doctor trained to do the
UGI or endoscopy test, nurse, and radiographer. In 2005,
f1.2 million Koreans, f20% of eligible persons ages
40 years and older, participated in the NCSP for gastric
cancer (13). In addition to the NCSP, the National Health
Insurance provides gastric cancer screening to their
beneficiaries and covers 80% of the costs of these services
through the National Health Insurance screening pro-
gram. Apart from the NCSP, UGI or endoscopy testing is
conducted in outpatient clinics or private health assess-
ment centers for opportunistic screening. However, in
these cases, individuals must pay for all procedure-
related costs associated with opportunistic screening.
Based on the 2006 national survey, f19% of men and
women ages 40 years and older had undergone
opportunistic screening within the previous 2 years (14).
Although the NCSP offers either UGI or endoscopy
examination as an initial screening method for gastric
cancer, there is a lack of agreement about the preferred
screening method among the government, physicians,
and the general population. For a program of this
magnitude to succeed, a high level of participation is
required, which likely depends on individuals’ attitudes
about the screening method used. Previous studies about
colorectal cancer screening have suggested that individ-
uals prefer to initiate tests that they believe to be the
most accurate (e.g., colonoscopy) or least invasive (e.g.,
fecal occult blood test) or the easiest and least expensive
(15-19). Moreover, based on a behavioral model, previous
studies reported that predisposing (age, gender, marital
status, and family history of colon cancer), enabling
(health insurance status, physician visit, and usual source
of care), and need (health status) factors were associated
with colorectal cancer screening use, and the relevance
attributed to screening use was in many cases test
specific (17, 20, 21). Further, the intention to have
colorectal cancer screening differed significantly by
screening status (22). For example, individuals who had
a prior colonoscopy were more likely to prefer an
invasive versus a noninvasive test (17).
However, screening for gastric cancer is not commonly
practiced, and there is a paucity of data to lend support
to such a program. To our knowledge, no study has
investigated the preferred screening methods for gastric
cancer (UGI versus endoscopy). In addition, the influ-
ence of prior experiences on future preferences has not
been investigated. Although the effectiveness of mass
screening for gastric cancer remains controversial,
countries with a high incidence of gastric cancer, such
as Japan and Korea, have implemented nationwide
gastric cancer screening programs and have made an
effort to promote cancer screening. Therefore, under-
standing people’s experiences with and preferences for
gastric cancer screening methods may provide informa-
tion necessary for optimizing screening adherence.
The objectives of this study were to assess the rates of
gastric cancer screening by two screening methods and
to determine the preferred method for widespread
screening from a population-based survey of Korea. We
examined the gastric cancer screening rates for different
screening methods and the factors associated with the
use or nonuse of tests. We also examined the intention to
be screened for gastric cancer in the future and the
preferred method of screening and its associated factors.
Materials and Methods
Study Population. This study was based on the 2006
Korean National Cancer Screening Survey, an annual
cross-sectional survey that uses a nationally representa-
tive random sampling to investigate Korean participation
rates in cancer screening for five common cancers:
gastric, liver, colorectal, breast, and cervix (23). A total
of 4,687 men and women were selected based on the 2005
Resident Registration Population data using a stratified,
multistage, and random sampling according to geo-
graphic area, age, and gender. The Resident Registration
Population is published annually by the Korea National
Statistical Office after data are gathered from residents
of the registration population every December 31. The
publication provides data about changes in population
size and structure and identifies population changes by
administrative district (24).
For the current study, investigators from a profession-
al research agency conducted face-to-face interviews in
the participants’ homes. Study recruitment involved
door-to-door contact. We made at least three attempts
to contact a resident in each dwelling. Study eligibility
was assessed through a face-to-face interview. Eligible
participants were asked about their experiences of
screening for five common cancers; health behaviors
such as smoking, physical activity, alcohol use, health
status, and family history of cancer; and socioeconomic
and demographic information. Interviews were complet-
ed by 2,033 participants (response rate, 43.4%; age z30 y)
with no previous cancer diagnosis. Of the 2,033 individ-
uals, cancer-free male and female participants 40 y or
older were included in this study. We excluded some
participants due to missing information: 23 subjects did
not report income and 27 did not report education; of
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the latter, 3 had already been excluded due to missing
income data. Finally, 1,625 participants were selected as
study subjects (Fig. 1). The lower age cutoff follows the
recommendation of NCSP for gastric cancer screening for
individuals 40 y of age and older (12). We obtained
informed consent from all study participants.
Measurement. The questions about gastric cancer
screening behaviors were developed to assess the
utilization rate of and preferred method for gastric
cancer screening (UGI versus endoscopy). The questions
were prefaced with a two-to-three-sentence description
of the test to help respondents differentiate between the
tests. The main distinguishing characteristics of the tests
cited were as follows: (a) UGI (barium enema) requires
an X-ray after drinking a cup of white fluid and (b)
endoscopy is done with a flexible tube in the physician’s
office. Previous experience was assessed by the following
questions: (a) whether the participant had ever been
screened for gastric cancer, (b) which tests the participant
underwent (UGI, endoscopy, or both), and (c) when the
participant underwent his/her most recent UGI or
endoscopy test. Respondents were categorized into one
of the following groups: (a) up-to-date screening (indi-
viduals had undergone either a UGI or endoscopy test in
the previous 2 y based on clinical NCSP guidelines;
ref. 12), (b) prior but not up-to-date screening (individ-
uals had undergone either a UGI or endoscopy test at
least once but not within the previous 2 y), or (c) no
screening (individuals had never undergone either a UGI
or an endoscopy test). The primary outcome measures
assessed up-to-date gastric cancer screening, specifically
(a) UGI use within the previous 2 y, (b) endoscopy use
within the previous 2 y, and (c) either test (UGI and/or
endoscopy) conducted within the previous 2 y. The
information about the reason for screening, that is,
whether the screening was conducted for screening
purposes or symptom/diagnostic purposes, and test
results were not collected for individuals who indicated
that they had undergone either UGI or endoscopy tests.
Screening intention was measured by asking partic-
ipants the following: ‘‘Do you have any intention to get
screened for gastric cancer within the next two years?
(1 = yes; 2 = no)’’. In addition, all respondents, including
those who had no intention of getting screened, were
asked to select one preference from the choices of UGI
and endoscopy. Based on a previous study (19), we
selected a forced choice response format because the
primary purpose was to determine the preferred method
of gastric cancer screening between the UGI and
endoscopy in a general population.
We also examined demographic and socioeconomic
factors (e.g., gender, age, education, and household
income) that might affect decisions about gastric cancer
screening. Household income was categorized into three
groups based on monthly household post-tax income
(US$1 = 1,000 won). We also included questions on
whether individuals had ever had health checkups
(including a physical examination) in their lifetime,
which were considered a proxy for the ability to afford
and/or have access to health care. We considered the
subjects’ family histories of gastric cancer, where
‘‘family’’ included only blood relatives, including half-
siblings. With regard to health behavior, we ascertained
smoking status and alcohol consumption. The partic-
ipants were classified as current smokers if they reported
Figure 1. Participant selection process.
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current smoking for at least 1 y or as nonsmokers if they
had never smoked or had previously smoked but had not
smoked for more than 1 y. For alcohol consumption,
participants were asked, ‘‘During the past 30 days, how
often did you have at least one drink of any alcoholic
beverage?’’ For the main analysis, the participants were
categorized as ‘‘none in the past 30 days,’’ ‘‘once a week
or less,’’ ‘‘two or three days per week,’’ or ‘‘four or more
days per week.’’
Statistical Analysis. Descriptive statistics were com-
puted for all demographic, socioeconomic, health
behavior, and dependent variables, including the fre-
quency distribution for each categorical variable. We first
did bivariate analyses to evaluate unadjusted effects of
each variable and then conducted multivariate analyses
to examine the adjusted associations of these variables
with (a) up-to-date gastric cancer screening procedure
use (UGI, endoscopy, and either UGI and/or endosco-
py), (b) the intention to have future screening (intention
versus no intention), and (c) preferences for future
gastric cancer screening methods (endoscopy versus
UGI) in a population. We used multiple logistic
regressions in all of our adjusted analyses. Three
multivariate models were used to determine the inde-
pendent variables associated with undergoing up-to-date
gastric cancer screening by each method: UGI within the
previous 2 y, endoscopy within the previous 2 y, and
either or both within the previous 2 y. Additional models
were designed to identify the factors associated with
Table 1. Descriptive information for the sample population and UGI, endoscopy, or any test use in the previous 2 y
Characteristics Total (n = 1,625) Screening strategy
UGI* Endoscopy
c
Any test
b
n (%) % % %
Totals
No. participants — 1,625 1,625 1,625
No. screened — 245 540 701
Percent screened — 15.1 33.2 43.1
Gender
Male 792 (48.7) 12.9 32.2 40.0
Female 833 (51.3) 17.2 34.2 46.1
P 0.016 0.388 0.014
Age (y)
40-49 683 (42.0) 12.5 29.3 36.9
50-59 428 (26.3) 14.7 35.3 45.3
60-69 380 (23.4) 21.6 39.5 53.7
z70 134 (8.3) 11.2 29.1 38.1
P 0.001 0.004 <0.001
Education (y)
Did not complete high school 711 (43.7) 17.3 34.5 46.8
High school graduate or above 914 (56.3) 13.4 32.3 40.3
P 0.027 0.354 0.009
Monthly household income (US$)
<2,000 689 (42.4) 16.4 32.2 44.7
2,000-2,999 455 (28.0) 13.6 30.6 39.3
z3,000 481 (29.6) 14.6 37.2 44.5
P 0.408 0.073 0.156
Previous health checkup
No 413 (25.4) 5.6 13.3 17.7
Yes 1,137 (70.0) 19.0 40.2 52.5
Missing (don’t know) 75 (4.6) 8.0 37.3 41.3
P <0.001 <0.001 <0.001
Family history of gastric cancer
No 1,571 (96.7) 11.1 50.0 53.7
Yes 54 (3.3) 15.2 32.7 42.8
P 0.526 0.008 0.111
Smoking status
Current smoker 419 (25.8) 14.1 27.7 35.6
Ex-smoker 196 (12.1) 12.2 35.7 43.4
Nonsmoker 1,010 (62.1) 16.0 35.1 46.2
P 0.319 0.020 0.001
Alcohol consumption
None in the past 30 d 878 (54.0) 16.5 35.0 45.6
Once a week or less 326 (20.1) 13.5 30.1 39.3
Two or 3 d per week 233 (14.3) 12.9 32.6 42.9
Four or more days per week 188 (11.6) 13.8 31.4 38.8
P 0.367 0.392 0.138
*Individuals had undergone a UGI test in the previous 2 y.
cIndividuals had undergone an endoscopy test in the previous 2 y.
bIndividuals had undergone either a UGI or endoscopy, or both tests in the previous 2 y. The number screened does not equal the sum of participants
(i.e., individuals may have had more than one test).
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having an intention to be screened and preference for
one of the two screening tests (endoscopy versus UGI).
We added the individuals’ gastric screening history
(up-to-date screening, prior but not up-to-date screening,
and no screening) and method of previous cancer
screening within the previous 2 y (UGI, endoscopy,
and both) as independent variables to evaluate the
influence of prior experiences on future screening
intention and preferred methods. All statistical analyses
were conducted using Statistical Analysis System statis-
tical software (version 9.1; SAS Institute, Inc.).
Results
Sample Characteristics. Of the 1,625 survey respond-
ents, approximately 51% were women, 42% were 40 to 49
years old, 56% were educated at a high school level or
above, and f3% had a family history of gastric cancer.
With regard to gastric cancer screening history, 43.1 of
respondents had undergone either a UGI or endoscopy
test in the previous 2 years (up-to-date screening), 10.3%
had undergone either a UGI or endoscopy test at least
once but not within the previous 2 years (prior but not
up-to-date screening), and 46.6% had never undergone
either a UGI or endoscopy test (no screening; Fig. 1).
Rate of Gastric Cancer Screening in the Previous
2 Years. Among the 1,625 subjects ages 40 years and
older, 245 (15.1%) had undergone UGI testing, 540
(33.2%) had received an endoscopy test, and 701
(43.1%) had undergone either or both of the two tests
within the previous 2 years (Table 1). In bivariate
analyses, women were more likely to have had UGI
screening than men. UGI test rates increased with
increasing age until 60 to 69 years and then decreased.
Respondents who were less educated and had under-
gone a recent health checkup were more likely to report
having had an UGI test than other respondents.
Respondents differed significantly in endoscopy use by
age, health checkup, family history of gastric cancer, and
smoking status. Patterns of associations with endoscopy
use by age and health checkup were similar to those for
UGI use. However, individuals with a family history
of gastric cancer were more likely to report having
undergone an endoscopy test than those without such a
history. Current smokers reported lower rates of endos-
copy use than nonsmokers. Finally, patterns of associa-
tions for any test (UGI and/or endoscopy) were similar
to those for UGI use, with one exception: current smokers
reported lower rates of having undergone any test.
Factors Associated with Gastric Cancer Screening
in the Previous 2 Years. Table 2 lists the adjusted
associations of subjects’ characteristics with their use of
Table 2. Logistic regression for UGI, endoscopy, or any test in the previous 2 y
Characteristics Model 1: UGI* (n = 1,625) Model 2: endoscopy
c
(n = 1,625) Model 3: any test
b
(n = 1,625)
aOR (95% CI) aOR (95% CI) aOR (95% CI)
Gender
Male 1.00 (reference) 1.00 (reference) 1.00 (reference)
Female 1.33 (0.85-2.10) 0.75 (0.54-1.05) 0.86 (0.62-1.19)
Age (y)
40-49 0.88 (0.61-1.28) 0.78 (0.59-1.03) 0.75 (0.57-0.98)
50-59 1.00 (reference) 1.00 (reference) 1.00 (reference)
60-69 1.51 (1.03-2.23) 1.23 (0.90-1.68) 1.38 (1.01-1.87)
z70 0.76 (0.41-1.44) 0.88 (0.56-1.39) 0.82 (0.53-1.26)
Education (y)
Did not complete high school 1.00 (reference) 1.00 (reference) 1.00 (reference)
High school graduate or more 0.91 (0.64-1.31) 0.92 (0.70-1.22) 0.88 (0.67-1.15)
Monthly household income (US$)
<2,000 1.00 (reference) 1.00 (reference) 1.00 (reference)
2,000-2,999 0.93 (0.64-1.35) 1.01 (0.75-1.34) 0.89 (0.68-1.18)
z3,000 1.00 (0.69-1.46) 1.42 (1.07-1.89) 1.16 (0.88-1.54)
Previous health checkup
No (missing/don’t know) 1.00 (reference) 1.00 (reference) 1.00 (reference)
Yes 3.65 (2.43-5.49) 3.26 (2.49-4.27) 4.12 (3.21-5.30)
Family history for gastric cancer
No 1.00 (reference) 1.00 (reference) 1.00 (reference)
Yes 0.66 (0.27-1.57) 2.05 (1.17-3.60) 1.53 (0.86-2.70)
Smoking status
Current smoker 1.00 (reference) 1.00 (reference) 1.00 (reference)
Ex-smoker 0.77 (0.45-1.29) 1.29 (0.88-1.88) 1.20 (0.83-1.73)
Nonsmoker 0.86 (0.53-1.38) 1.65 (1.16-2.36) 1.69 (1.19-2.38)
Alcohol consumption
None in the past 30 d 1.00 (reference) 1.00 (reference) 1.00 (reference)
Once a week or less 0.90 (0.61-1.33) 0.86 (0.64-1.16) 0.90 (0.68-1.20)
Two or 3 d per week 0.90 (0.56-1.43) 0.96 (0.67-1.36) 1.08 (0.77-1.52)
Four or more days per week 1.05 (0.62-1.76) 1.02 (0.69-1.51) 1.03 (0.71-1.52)
Abbreviations: aOR, adjusted odds ratio; 95% CI, 95% confidence interval.
*Individuals had undergone a UGI test in the previous 2 y.
cIndividuals had undergone an endoscopy test in the previous 2 y.
bIndividuals had undergone either a UGI or endoscopy, or both tests in the previous 2 y. The number screened does not equal the sum of participants (i.e.,
individuals may have had more than one test).
Screening for Gastric Cancer in Korea
Cancer Epidemiol Biomarkers Prev 2009;18(5). May 2009
1394
on April 7, 2015. © 2009 American Association for Cancer Research. cebp.aacrjournals.org Downloaded from 
gastric cancer screening procedures. Individuals ages
60 to 69 years were more likely to have undergone a
UGI test than those ages 50 to 59 years. In addition,
individuals who had undergone a health checkup were
more likely to have had a UGI test than those who had
not. As with UGI use, individuals who had undergone
a health checkup were more likely to have had an
endoscopy test. Endoscopies were significantly more
likely among those with higher income and a family
history of gastric cancer. Among health behavior factors,
nonsmokers were more likely to have had an endoscopy
test compared with current smokers. Overall, individuals
who had been screened for gastric cancer within the
previous 2 years were more likely to be older, to be
nonsmokers, and to have health checkups.
Intention to Have Gastric Cancer Screening. With
regard to future gastric cancer screening intentions, 848
(52.2%) participants intended to be screened within the
next 2 years (Table 3). The rate of intention to be screened
was significantly higher in women compared with men.
Individuals ages 50 to 59 years were the more likely to
report an intention to be screened in the future compared
with other age groups. In addition, individuals with
more education, those with higher income, and those
who had undergone a health checkup had higher rates of
intention to be screened. Nonsmokers had higher rates of
intention compared with current or ex-smokers. Individ-
uals who had been screened for gastric cancer within the
previous 2 years were more likely to have an intention to
be screened in the future than those who had not been
previously screened or those who had undergone
screening but not up-to-date screening. Further, individ-
uals who had undergone either a UGI test or both UGI
and endoscopy testing were more likely to have an
intention to be screened than those who had undergone
only an endoscopy or those who did not have up-to-date
screening.
Preference for Future Gastric Cancer Screening
Method. Of the 1,625 participants, 1,085 (67.0%) chose
endoscopy and 540 (33.0%) chose UGI for their preferred
future screening method (Table 3). Individuals with a
higher income were significantly more likely to prefer
Table 3. Intention to have gastric cancer screening within the next 2 y and preferred method
Characteristics Having screening intention (n = 1,625) Preference for future screening method (n = 1,625)
% P UGI (%) Endoscopy (%) P
Total 52.2 — 33.0 67.0 —
Gender
Male 49.4 0.027 32.8 67.2 0.896
Female 54.9 33.1 66.9
Age (y)
40-49 55.2 <0.001 32.8 67.2 0.893
50-59 57.7 32.9 67.1
60-69 48.4 34.2 65.8
z70 30.6 30.6 69.4
Education (y)
Did not complete high school 45.4 <0.001 34.6 65.4 0.222
High school graduate or more 57.4 31.7 68.3
Monthly household income (US$)
<2,000 47.0 <0.001 36.9 63.1 0.017
2,000-2,999 52.3 30.1 69.9
z3,000 59.5 30.2 69.8
Previous health checkup
No 35.4 <0.001 36.8 63.2 0.115
Yes 58.9 31.4 68.6
Missing (don’t know) 42.7 36.0 64.0
Family history for gastric cancer
No 52.0 0.435 33.2 66.8 0.408
Yes 57.4 27.8 72.2
Smoking status
Current smoker 46.8 0.036 32.7 67.3 0.972
Ex-smoker 53.6 33.7 66.3
Nonsmoker 54.2 33.0 67.0
Alcohol consumption
None in the past 30 d 51.4 0.520 34.5 65.5 0.462
Once a week or less 55.5 30.1 69.9
Two or 3 d per week 53.2 33.0 67.0
Four or more days per week 48.9 30.9 69.1
Previous screening history
No screening 30.5 <0.001 37.3 62.7 0.001
Prior screening 53.9 35.3 64.7
Up-to-date screening 75.2 27.8 72.2
Previous screening methods
No up-to-date screening* 34.7 <0.001 36.9 63.1 <0.001
UGI (V2 y) 81.4 52.2 47.8
Endoscopy (V2 y) 71.1 18.6 81.4
Both (V2 y) 82.1 31.0 69.0
*Includes no screening and prior screening but not up-to-date screening.
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endoscopy testing to UGI testing compared with
individuals with a lower income. Endoscopy tests were
preferred by the majority of respondents who had
undergone an endoscopy test within the previous 2
years. However, individuals who had undergone a UGI
test preferred the UGI test to the endoscopy test.
Factors Associated with Intention to be Screened.
Table 4 presents the results of the multivariate models of
intention to be screened within the next 2 years. Women
were more likely to report having an intention to be
screened within the next 2 years than were men.
However, whereas individuals ages 60 to 69 or 70 and
older were less likely to report an intention to be
screened within the next 2 years compared with those
ages 50 to 59 years, individuals who were highly
educated and those who had undergone a health
checkup had significantly higher odds of reporting an
intention to be screened compared with those who had
less education or who had not undergone a health
checkup. Those who had undergone a UGI test, an
endoscopy test, or both tests within the previous 2 years
had 11.79, 11.12, and 6.22 higher odds of intending to be
screened again, respectively, than those who had not
been screened. In addition, those who had undergone
gastric cancer screening but not up-to-date screening had
higher odds of having an intention to be screened than
those who had not been screened.
Factors Associated with Preferred Method. With
regard to preference for future screening method,
individuals who had undergone an endoscopy test
within the previous 2 years were significantly more
likely to prefer endoscopy to UGI testing, whereas
individuals who had undergone UGI testing within the
previous 2 years were less likely to prefer endoscopy
(Table 4). In addition, individuals with a household
income US$2,000 to US$2,999 were 1.39 times more likely
to prefer endoscopy than those with a lower household
income. However, other socioeconomic and health
behavior factors did not significantly affect preferences
for future screening method.
Discussion
Gastric cancer screening remains underused in Korea;
only 43% of the targeted Korean population had
undergone gastric cancer screening within the previous
2 years. It is difficult to make direct comparisons between
Table 4. Logistic regression for reporting an intention to undergo gastric cancer screening and preferences for
endoscopy over UGI
Characteristics Intention vs no intention (n = 1,625) Endoscopy vs UGI (n = 1,625)
aOR (95%CI) aOR (95% CI)
Gender
Male 1.00 (reference) 1.00 (reference)
Female 1.43 (1.01-2.02) 1.10 (0.79-1.54)
Age (y)
40-49 0.92 (0.69-1.24) 0.95 (0.72-1.26)
50-59 1.00 (reference) 1.00 (reference)
60-69 0.62 (0.45-0.87) 1.08 (0.79-1.48)
z70 0.37 (0.23-0.60) 1.39 (0.89-2.17)
Education (y)
Did not graduate from high school 1.00 (reference) 1.00 (reference)
High school graduate or more 1.71 (1.27-2.28) 1.07 (0.81-1.41)
Monthly household income (US$)
<2,000 1.00 (reference) 1.00 (reference)
2,000-2,999 1.00 (0.75-1.35) 1.39 (1.05-1.85)
z3,000 1.27 (0.94-1.71) 1.32 (0.99-1.76)
Previous health checkup
No (missing/don’t know) 1.00 (reference) 1.00 (reference)
Yes 1.37 (1.06-1.76) 1.13 (0.89-1.44)
Family history for gastric cancer
No 1.00 (reference) 1.00 (reference)
Yes 0.91 (0.49-1.69) 1.04 (0.56-1.95)
Smoking status
Current smoker 1.00 (reference) 1.00 (reference)
Ex-smoker 1.31 (0.88-1.93) 0.88 (0.61-1.29)
Nonsmoker 1.08 (0.75-1.55) 0.95 (0.67-1.35)
Alcohol consumption
None in the past 30 d 1.00 (reference) 1.00 (reference)
Once a week or less 1.28 (0.95-1.74) 1.28 (0.95-1.71)
Two or 3 d per week 1.18 (0.82-1.68) 1.11 (0.79-1.57)
Four or more days per week 1.21 (0.81-1.82) 1.27 (0.86-1.87)
Gastric cancer screening history
No screening 1.00 (reference) 1.00 (reference)
Prior screening 2.94 (2.04-4.23) 1.09 (0.76-1.56)
Up-to-date screening with
UGI (V2 y) 11.79 (7.49-18.58) 0.54 (0.38-0.78)
Endoscopy (V2 y) 6.22 (4.70-8.24) 2.57 (1.92-3.44)
Both (V2 y) 11.12 (6.06-20.41) 1.26 (0.77-2.08)
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studies because, to our knowledge, no previous study
has investigated the gastric cancer screening rate using
a population-based sample. Individuals who had been
screened for gastric cancer within the previous 2 years
were more likely to be older, nonsmokers, or those who
have regular health checkups. Factors associated with
gastric cancer screenings are similar to those found in
colorectal cancer screening (21, 25). About screening
methods, rates of endoscopy testing (32.2% and 34.2%)
were more than double those of UGI testing (12.9% and
17.2%) in both men and women, respectively. Similarly,
the prevalence of colorectal cancer screening using
endoscopy (i.e., flexible sigmoidoscopy or colonoscopy)
was more than twice as prevalent as screening by the
fecal occult blood test among both men and women in
the United States (21, 26). The factors for having had an
endoscopy test differed somewhat from those for having
had a UGI test. Interestingly, respondents with higher
income levels were more likely to have had an
endoscopy test. Under the Korean health insurance
system, the cost of an endoscopy test is almost the
same as that for a UGI test. In addition, the NCSP offers
free-of-charge endoscopy test for gastric cancer screen-
ing. Despite these programs, disparities in the use of
endoscopy vary with household income, possibly sug-
gesting that misconceptions exist about the cost of
endoscopy. In addition, the higher rates of endoscopy
use in those with a family history of gastric cancer might
indicate that the endoscopy test was the preferred test for
a high-risk population.
Approximately 52% of the people in this study
reported an intention to be screened for gastric cancer
within the next 2 years. Identifying the factors associated
with screening intention is important because studies
have consistently found a positive association between
intention and completion of several cancer screening
behaviors (22, 27, 28). In our study, women, individuals
who were highly educated, and those who had under-
gone a health checkup had significantly higher odds of
reporting an intention to be screened. However, those
ages 60 and older were less likely to report an intention
to be screened within the next 2 years. These differences
in screening intention highlight a need for interventions
targeted at the large proportion of individuals having no
intention of complying with screening recommendations,
particularly males, those over 60 years of age, those with
less education, and those who have never had a health
checkup. In addition, our findings revealed that individ-
uals who had undergone up-to-date screening are more
likely to be screened according to gastric cancer
screening recommendations. Further, individuals who
had undergone a UGI test within the previous 2 years
had the highest intention to be screened.
With regard to gastric cancer screening preferences,
endoscopy was preferred by the majority of respondents
(67.0%). Prior experience with screening procedures was
strongly associated with a preference for a future
screening procedure. Individuals who had received a
prior endoscopy test were significantly more likely to
prefer an endoscopy test to a UGI test, whereas
individuals who had previously undergone a UGI test
were less likely to prefer an endoscopy test. This may
be the result of education and information acquired
at previous screening tests. Our findings are somewhat
consistent with previous research, which found that
individuals who had previously undergone a colono-
scopy were significantly more likely to prefer an invasive
(e.g., sigmoidoscopy or colonoscopy) versus a noninva-
sive (e.g., fecal occult blood test) test (17). Reasons for this
preference may involve psychological and test-specific
characteristics. Previous studies showed that those who
selected endoscopy (e.g., colonoscopy or sigmoidoscopy)
reported that the accuracy of the test was the most
important reason for their choice (17-19). Discomfort was
reported as an important decisional factor for those
who were more likely to prefer a noninvasive test (17).
Therefore, clinicians, public health workers, and policy-
makers must carefully consider the messages that are
communicated to the public about gastric cancer test
options.
We examined gastric cancer screening use and
preferences for future screening procedures in a popu-
lation sample. However, this study had some limitations
that must be considered when interpreting the results.
First, Korean National Cancer Screening Survey data
were self-reported, which may have introduced a bias, as
several studies have suggested that self-reports overes-
timate the prevalence of cancer screening (29, 30).
Second, we were unable to explore the influence of other
important correlates, such as test-specific characteristics
(e.g., preparation, cost, time constraints, transportation,
or geographic capacity for screening) and psychological
factors (e.g., discomfort, concern about complications,
or anxiety about the procedure) involved in utilization
of gastric cancer screening and preference for future
methods. Third, items designed to assess screening test
preferences may not predict respondents’ actual prefer-
ences. Because we used a forced choice format when
asking about screening tests, individuals who would
have preferred no screening or those who had no
preference were included in the analysis. However,
when we did the analysis to assess the associated factors
with preferred method among those who had an
intention to be screened, the patterns of association were
similar to those for preferences in a population (results
not shown). Finally, the cross-sectional design used in
this study precludes conclusions about whether observed
associations were causal.
Collectively, our study results highlight that the
endoscopy test is the preferred gastric cancer screening
method according to a population-based survey. Recent
reports have proposed endoscopic screening as an
alternative strategy to radiography (8, 31). Although
endoscopy is generally considered to have a high
detection rate, its sensitivity compared with that of
radiography is unclear based on population-based
screenings (31). Moreover, endoscopy is an invasive test
that must be done by a physician. Therefore, endoscopy
tests depend heavily on the skills of the endoscopist and
on the availability of a gastroscope. Even assuming that
the capacity exists to do screening endoscopies on every
age-eligible person at the recommended frequency, we
recommend caution in promoting endoscopy over UGI
as a gastric cancer screening test. Our data show that
roughly half of previous UGI users preferred UGI to
endoscopy based on their prior experience. Therefore,
reliance on endoscopy alone may be insufficient to
ensure high participation in gastric cancer screenings at
a population level.
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The options for gastric cancer screening tests allow for
flexibility but can also render decisions about recom-
mending or choosing a particular test difficult. Each test
has its tradeoffs in terms of efficacy, complications,
discomfort, time, and cost (21). The best test is a matter of
personal preference, which should be considered when
physicians make recommendations for screening (15).
Providers’ (clinicians, public health workers, and policy-
makers) assessments of individuals’ screening preferen-
ces, in combination with intervention strategies to
promote performance of the preferred screening method,
may increase compliance with gastric cancer screening
recommendations. Future research should investigate
ways to improve shared decision making in test
selection, specifically within a Korean context. In
addition, we recommend further studies of cancer
detection rates, participation rates, economic costs, and
the side effects of different screening modalities in
populations.
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